Charge variant analysis of antibody-drug conjugates using an icIEF-UV/MS workflow

contributed by SCIEX | 09/20/2024

This technical note demonstrates a novel integrated workflow using the Intabio ZT system for charge variant analysis of antibody-drug conjugates (ADCs). This innovative system offers direct chip-based integration of icIEF with mass spectrometry (MS), achieving separation and confident identification of proteoforms with different payloads, reliable quantitation of charge variants and determination of drug-to-antibody ratios (DARs). Further, the streamlined icIEF-UV/MS platform significantly reduces acquisition and analysis time compared to ion exchange chromatography (IEX) with fraction collection, eliminating multiple weeks of effort.1

The icIEF-UV/MS data were interpreted using an Intabio intact icIEF-UV/MS workflow within Biologics Explorer software for automated protein deconvolution and accurate DAR calculation. With a single injection, 8 different trastuzumab emtansine (T-DM1) payloads were electrophoretically separated and an average DAR of 3.6 was measured.

Log in or register to read this article in full and gain access to The Analytical Scientist’s entire content archive. It’s FREE!

Email*

Choose a password*

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

Receive communication from The Cannabis Scientist I want to stay up to date with the Mass Spectrometry field I want to stay up to date with the Spectroscopy field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.